Дьяконов, В.А.,
Джемилева, Л.У.,
Макаров, А.А.,
Мулюкова, А.Р.,
Хуснутдинова, Э.К.,
Джемилев, У.М.,
Толстикова Т. Г.,
Baev, D.S.,
D`yakonov, V.A.,
Dzhemileva, L.U.,
Makarov, A.A.,
Mulyukova, A.R.,
Khusnutdinova, E.K.,
Dzhemilev, U.M.,
Tolstikova, Tatiana G. (2015) ) was detected. Resorting to the data of
molecular docking, a mechanism of inhibition was proposed.
Nurgalieva, A.Kh.,
Bashkatov, S.A.,
Volkova, E.V.,
Petrova, S.G.,
Takhirova, Z.R.,
Mustafin, R.N.,
Fedorova, Y.Y.,
Prokofyeva, D.S.,
Khusnutdinova, E.K. (2023) of future endeavors. There has been conducted a
molecular genetic study of the frequency distribution
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patients were revealed. The obtained data could be important for understanding of the
molecular mechanisms
Kazantseva, A.V.,
Davydova, Y.D.,
Enikeeva, R.F.,
Valinurov, R.G.,
Gareeva, A.E.,
Khusnutdinova, N.N.,
Khusnutdinova, E.K. (2021) by
molecular mechanisms related to the functioning of oxytocin (OXTR) and arginine vasopressin receptor (AVPR1B
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) attractive for use as prognostic
molecular genetic biomarkers. We evaluated exosomal miRNAs (miRNA-424, -146a
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) , which will make it possible both to identify new
molecular markers of the risk of developing the disease